Market Cap | 6.91M | P/E | 0.83 | EPS this Y | - | Ern Qtrly Grth | - |
Income | 2.47M | Forward P/E | 0.98 | EPS next Y | - | 50D Avg Chg | -3.00% |
Sales | 25.56M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -45.00% |
Dividend | N/A | Price/Book | 0.18 | EPS next 5Y | - | 52W High Chg | -86.00% |
Recommedations | - | Quick Ratio | 0.76 | Shares Outstanding | 3.97M | 52W Low Chg | 20.00% |
Insider Own | 6.58% | ROA | 3.88% | Shares Float | 1.33M | Beta | -1.25 |
Inst Own | 1.75% | ROE | 6.61% | Shares Shorted/Prior | 111.84K/10.66K | Price | 0.62 |
Gross Margin | 27.75% | Profit Margin | 9.65% | Avg. Volume | 263,174 | Target Price | 77.50 |
Oper. Margin | 0.83% | Earnings Date | Oct 28 | Volume | 93,026 | Change | -1.59% |
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.